Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 69 Fallopian Tube Neoplasms 18 Endometrial Neoplasms 8 Carcinoma, Ovarian Epithelial 8 Breast Neoplasms 7 Neoplasms 5 Pancreatic Neoplasms 3 Cystadenocarcinoma, Serous 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Prostatic Neoplasms 2 Ovarian Diseases 2 Neoplasm Metastasis 2 Gonadal Disorders 2 Genital Neoplasms, Female 2 Genital Diseases, Female 2 Endocrine System Diseases 2 Endocrine Gland Neoplasms 2 Carcinoma 2 Adnexal Diseases 2 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Sarcoma 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Recurrence 1 Prostatic Diseases 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Platinum-resistant Ovarian Cancer 1

Interventions

anlotinib 2 niraparib 1 afuresertib 1 Paclitaxel 1 PHI-101 1 Gemcitabine 1 ALT-803 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Platinum-resistant Ovarian Cancer × niraparib × Gynecologic × Clear all

NCT04376073 2020-11-25

ANNIE

Sun Yat-sen University

Phase 2 Unknown

Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡